Lotus Eye Hospital and Institute Limited
NSE:LOTUSEYE.NS
73.36 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 482.099 | 470.439 | 380.862 | 316.668 | 399.81 | 379.788 | 375.041 | 339.647 | 311.322 | 298.98 | 286.945 | 291.084 | 262.257 | 191.409 | 141.686 | 116.765 | 107.356 |
| Kosten van de omzet
| 364.703 | 219.848 | 188.239 | 156.529 | 189.492 | 181.793 | 178.462 | 167.802 | 144.903 | 151.891 | 79.688 | 84.844 | 84.897 | 28.319 | 43.172 | 23.936 | 21.423 |
| Brutowinst
| 117.396 | 250.591 | 192.623 | 160.139 | 210.318 | 197.995 | 196.579 | 171.845 | 166.419 | 147.089 | 207.257 | 206.24 | 177.36 | 163.09 | 98.514 | 92.829 | 85.933 |
| Brutowinstmarge
| 0.244 | 0.533 | 0.506 | 0.506 | 0.526 | 0.521 | 0.524 | 0.506 | 0.535 | 0.492 | 0.722 | 0.709 | 0.676 | 0.852 | 0.695 | 0.795 | 0.8 |
| Onderzoek- en ontwikkelingskosten
| 0.536 | 0.488 | 0.831 | 0.498 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 76.591 | 20.528 | 5.166 | 5.211 | 6.678 | 8.325 | 9.753 | 8.342 | 9.192 | 26.588 | 9.685 | 7.694 | 0 | 0 | 0 | 0 | 0 |
| Verkoop- en marketingkosten
| 12.78 | 13.467 | 9.897 | 3.31 | 12.777 | 11.568 | 8.121 | 4.851 | 1.378 | 4.213 | 4.708 | 6.545 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 89.371 | 33.995 | 15.063 | 8.521 | 19.455 | 19.893 | 17.874 | 13.193 | 10.57 | 30.801 | 40.922 | 37.166 | 0 | 0 | 0 | 0 | 0 |
| Overige kosten
| 13.027 | 11.455 | 4.358 | 3.515 | 4.573 | 5.123 | 5.242 | 3.528 | 155.376 | 169.766 | 208.907 | 203.607 | 198.513 | 155.279 | 93.743 | 69.273 | 53.693 |
| Bedrijfskosten
| 89.371 | 204.531 | 158.289 | 144.858 | 194.764 | 193.351 | 182.742 | 173.141 | 165.946 | 169.766 | 208.907 | 203.607 | 198.513 | 155.279 | 93.743 | 69.273 | 53.693 |
| Bedrijfsresultaat
| 28.025 | 50.32 | 36.433 | 14.3 | 16.183 | 4.644 | 13.837 | -1.296 | 0.473 | -22.677 | -1.65 | 2.633 | -21.153 | 7.811 | 4.771 | 23.556 | 32.24 |
| Bedrijfsresultaat ratio
| 0.058 | 0.107 | 0.096 | 0.045 | 0.04 | 0.012 | 0.037 | -0.004 | 0.002 | -0.076 | -0.006 | 0.009 | -0.081 | 0.041 | 0.034 | 0.202 | 0.3 |
| Totaal overige inkomsten en kosten netto
| 12.112 | 6.201 | 4.503 | 5.623 | -1.628 | 1.635 | 3.187 | 5.313 | -0.678 | 0.434 | 2.648 | 1.911 | -0.487 | -1.037 | -5.186 | -8.337 | -8.636 |
| Inkomen voor belasting
| 40.137 | 56.521 | 40.936 | 19.922 | 14.555 | 6.279 | 17.024 | 4.017 | -0.205 | -22.243 | 0.998 | 4.544 | -21.64 | 6.774 | -0.415 | 15.219 | 23.604 |
| Inkomen voor belasting ratio
| 0.083 | 0.12 | 0.107 | 0.063 | 0.036 | 0.017 | 0.045 | 0.012 | -0.001 | -0.074 | 0.003 | 0.016 | -0.083 | 0.035 | -0.003 | 0.13 | 0.22 |
| Belastingkosten
| 10.992 | 15.746 | 11.091 | 4.242 | 3.909 | -0.802 | -0.442 | -0.257 | -1.213 | -2.435 | 0.608 | 0.394 | 0.066 | 2.423 | 1.973 | 3.314 | 10.983 |
| Nettowinst
| 29.145 | 40.775 | 29.845 | 15.68 | 10.646 | 7.081 | 17.467 | 4.274 | 1.008 | -19.808 | 0.39 | 4.15 | -21.706 | 4.351 | -2.388 | 11.905 | 12.621 |
| Nettowinstmarge
| 0.06 | 0.087 | 0.078 | 0.05 | 0.027 | 0.019 | 0.047 | 0.013 | 0.003 | -0.066 | 0.001 | 0.014 | -0.083 | 0.023 | -0.017 | 0.102 | 0.118 |
| WPA (Winst Per Aandeel)
| 1.4 | 1.96 | 1.44 | 0.75 | 0.51 | 0.34 | 0.84 | 0.21 | 0.05 | -0.95 | 0.02 | 0.2 | -1.04 | 0.21 | -0.11 | 0.56 | 1.23 |
| Verwaterde WPA
| 1.4 | 1.96 | 1.44 | 0.75 | 0.51 | 0.34 | 0.84 | 0.21 | 0.05 | -0.95 | 0.02 | 0.2 | -1.04 | 0.21 | -0.11 | 0.56 | 1.23 |
| EBITDA
| 65.303 | 87.32 | 66.341 | 43 | 47.688 | 40.214 | 54.756 | 39.403 | 46.679 | 25.668 | 36.466 | 42.04 | 18.83 | 34.196 | 30.418 | 40.204 | 42.295 |
| EBITDA ratio
| 0.135 | 0.186 | 0.174 | 0.136 | 0.119 | 0.106 | 0.146 | 0.116 | 0.15 | 0.086 | 0.127 | 0.144 | 0.072 | 0.179 | 0.215 | 0.344 | 0.394 |